Latest News

Record steel shipments and expanded spreads drove 44% operating income growth.

Net income surged 25% as the bank cut wholesale deposits and strengthened capital.

Celsius trades at half Dutch Bros' valuation despite triple the free cash flow, but Pepsi dependency poses a hidden risk.

Today, Oct. 20, 2026, options traders priced in an 8% post-earnings swing as investors focus on launch cadence and government demand.

Mortgage cash flows have stabilized as extension risk peaked, making the portfolio's income stream far more predictable for income-focused investors.

Asset sensitivity and commercial borrower resilience position the bank to expand margins even as rates stabilize.

AbbVie generates $17.8 billion in annual free cash flow but faces patent cliffs, while Vertex boasts a 33% net margin with concentrated cystic fibrosis exposure.

A regional bank's ability to hold margins steady depends less on Fed policy than on disciplined funding decisions.

The U.S. Army's Janus Program is bringing opportunities to nuclear energy investors.

Data science and disciplined credit management are protecting profitability as the bank expands market share.

Margin expansion and near-record commercial lending suggest the bank's acquisition strategy is translating into tangible operating gains.

A rare multifamily agency license positions Zions to capture fee income competitors cannot, reshaping its long-term earnings mix.

The mortgage REIT posted a 16.9% tangible book-value drop in Q3, yet management projects 18-20% returns on new investments, today, Oct. 20, 2026.

What Happened? Shares of dialysis provider DaVita Inc. (NYSE:DVA) fell 7.1% in the afternoon session after Axios reported that the Department of Health and H...

What Happened? Shares of industrial conglomerate 3M (NYSE:MMM) jumped 5.2% in the afternoon session after the company reported third-quarter 2026 results, ra...

Cross-border banking company East West Bancorp (NASDAQ:EWBC) reported Q3 2026 results exceeding the market’s revenue expectations, with sales up 10.3% year o...

Loan growth and margin expansion offset trading headwinds.

Net income rose 6.4% as credit trends improved and deposit costs declined.

These electric vertical take-off and landing stocks both have a lot of promise, but both are also down big this year.

On Oct. 20, 2026, the customer engagement software maker's board unanimously backed the $47.50-per-share offer, confirming shareholder support.

On Oct. 20, 2026, the streaming giant reported engagement held steady despite price increases, signaling margin gains ahead.

Alibaba trades at a lower valuation multiple, but Home Depot's free cash flow advantage and professional contractor focus reveal starkly different risk-return profiles.

Agenus (NASDAQ:AGEN) is concentrating its registration strategy for BOT/BAL on the Phase III ROBBIN trial in neoadjuvant high-risk stage II and III microsatellite-stable (MSS) colon cancer, after ending funding for its BATTMAN study in later-line metastatic disease. Zack Armen, Agenus’ vice preside

Tamarack's target implies roughly 24% upside, while a cleaner balance sheet gives its Clearwater strategy room to work.

These drugmakers are facing some near-term challenges, but is that enough to stop their recent momentum?